ACLY and cancer: Studying the biology of cancers has revealed that the enzyme ATP citrate lyase (ACLY) [210], a fundamental enzyme for the de novo lipogenesis [211], is usually upregulated within the tumour and that miR-22 targets this gene as shown by Xin et al. [212].